Clinical Sandoz biosimilar trial hailed as 'landmark' Patients switched between the originator and the near-copy.
News Science minister Johnson concerned over EU science cash EU science funding would remain, at least for the time being.
News UK science funding uncertain after Brexit vote UK government says funding will continue until Brexit is resolved.
US FDA fast-tracks review of Roche's potential MS blockbuster Regulator to make decision by year end.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
